<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03913845</url>
  </required_header>
  <id_info>
    <org_study_id>Retropubic Lidocaine vs Saline</org_study_id>
    <nct_id>NCT03913845</nct_id>
  </id_info>
  <brief_title>The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling</brief_title>
  <official_title>The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling: A Randomized Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West Penn Allegheny Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West Penn Allegheny Health System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stress urinary incontinence affects millions of women worldwide and has a profound impact on
      the quality of life of older individuals, their subjective health status, levels of
      depression and need for care. Midurethral sling placement was introduced in 1995 and remains
      the current gold standard for surgical management of SUI. Although the advantages of
      midurethral sling surgery include its high success and minimally invasive approach,
      approximately 10-50% of women experience acute postoperative urinary retention and are
      subsequently sent home with an indwelling foley catheter or clean intermittent self
      catheterization. Urinary retention is anxiety provoking for most patients and adds morbidity,
      cost, and increased utilization of healthcare resources. Additionally, catheterization of the
      urinary tract results in increased risk of urinary tract infection and potential need for
      antibiotics.

      Several recent studies have reported varying rates of postoperative voiding trial success
      depending on the type of local anesthetic used for hydrodissection; however the data is
      sparse and invites a more thorough investigation. Furthermore, to the investigators
      knowledge, no studies have systematically explored dosage or type of agent used
      intraoperatively on postoperative voiding function. Based on the preliminary data, the
      investigators hypothesize that patients receiving normal saline compared to a local
      anesthetic (e.g., lidocaine) will have a reduction in duration of postoperative urinary
      retention following retropubic midurethral sling placement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim 1: to compare the incidence of urinary retention following retropubic midurethral sling
      placement in those women receiving normal saline vs lidocaine for retropubic hydrodissection.
      The investigators will compare rates of failed retrograde voiding trials between patients
      receiving normal saline to those receiving the same quantity of lidocaine. This will be
      completed using a standardized retrograde voiding trial 1-2 hours postoperatively (as
      outlined in &quot;Data and Statistical Methods&quot; below). The investigators hypothesize that
      patients receiving normal saline compared to a local anesthetic will have a reduction in
      postoperative urinary retention following retropubic midurethral sling placement.

      Aim 2: to assess postoperative pain in women receiving retropubic normal saline vs lidocaine
      during midurethral sling placement. Postoperatively, subjects will be asked to mark their
      pain on a VAS scale administered 2 hours and 6 hours following surgery. The initial
      assessment will be performed by nursing personnel at the time of routine vital sign
      assessment; the subsequent assessments will be completed by patients with an at-home form
      through postoperative day #7. Narcotic use will be queried through the electronic medical
      record as well as with a pain diary administered at time of discharge until postoperative day
      #7.

      Aim 3: to examine differences in patient satisfaction and quality of life following
      retropubic midurethral sling placement between women receiving retropubic normal saline vs
      lidocaine at time of midurethral sling placement. Differences in patient satisfaction will be
      compared using a Likert Scale. Patients will be asked to rate their satisfaction with surgery
      on a Likert scale (with 1 being the least satisfied and 5 being the most) at their 6 week
      postoperative follow up visit. The investigators hypothesize that women receiving normal
      saline for hydrodissection will have improved patient satisfaction as evidenced by higher
      Likert scores compared to those receiving lidocaine.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 25, 2019</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of urinary retention</measure>
    <time_frame>This will be completed using a standardized retrograde voiding trial 1-2 hours postoperatively.</time_frame>
    <description>To compare the incidence of urinary retention following retropubic midurethral sling placement in those women receiving normal saline vs lidocaine for retropubic hydrodissection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain: VAS scale</measure>
    <time_frame>Subjects will be asked to mark their pain on a VAS scale administered 2 hours and 6 hours following surgery. The subsequent assessments will be completed by patients with an at-home form through postoperative day #7.</time_frame>
    <description>To assess postoperative pain in women receiving retropubic normal saline vs lidocaine during midurethral sling placement. Visual Analog Scale (VAS) pain scales are unidimensional measures of pain intensity that are easily completed and scored. Subjects place an &quot;X&quot; on a 10 centimeter (cm) VAS line at the point that represents their pain intensity. The score is calculated by measuring the distance in millimeters (mm) along the 10 cm line where 0 represents &quot;no pain&quot; and 10 represents &quot;worst pain.&quot; Scores range from 0-100mm. They have been widely used in diverse populations to assess pain. VAS pain scores will be used as the outcome measure in this study because they are easy to complete and because they are easily compared to prior studies. The 2 hour VAS score will be completed prior to discharge. The 6 hour VAS score will be returned via mail since patients are routine discharged a few hours after sling surgery.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient satisfaction following surgery: Likert Scale</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>To examine differences in patient satisfaction with surgery between women receiving retropubic normal saline vs lidocaine at time of midurethral sling placement. The Likert Scale is the most widely used approach to scaling responses in survey research and contains five tiered responses which users quantify on a visual analogue scale. The administration of such is easily comprehended, provides an effective and clinically relevant means of assessing patient satisfaction, and can readily be used in clinical practice. To determine satisfaction, patients will be asked to rate their satisfaction with surgery on a Likert scale (with 1 being the least satisfied and 5 being the most) at their 6 week postoperative follow up visit.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>0.5% lidocaine with epinephrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>On the day of surgery, the operating room pharmacist will prepare 20 cc of either study drug (0.5% lidocaine with epinephrine 1:200,000) or normal saline with epinephrine 1:200,000) in identical appearing 20cc syringes to be injected retropubically. Our group's routine clinical practice is to inject 20cc of 0.5% lidocaine with epinephrine 1:200,000 retropubically along the path of the midurethral sling trocars. Suburethral injection of local anesthestic will be performed at surgeon discretion. Surgical teams, anesthesia teams and patients will be blinded to allocation assignment. The investigational drug pharmacist will maintain the randomization sequence.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline with epinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>On the day of surgery, the operating room pharmacist will prepare 20 cc of either study drug (0.5% lidocaine with epinephrine 1:200,000) or normal saline with epinephrine 1:200,000) in identical appearing 20cc syringes to be injected retropubically. Our group's routine clinical practice is to inject 20cc of 0.5% lidocaine with epinephrine 1:200,000 retropubically along the path of the midurethral sling trocars. Suburethral injection of local anesthestic will be performed at surgeon discretion. Surgical teams, anesthesia teams and patients will be blinded to allocation assignment. The investigational drug pharmacist will maintain the randomization sequence.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine with epinephrine</intervention_name>
    <description>One of the most commonly used local anesthetic agents in surgical practice is lidocaine. Lidocaine as a local anesthetic is characterized by a rapid onset of action (typically within 2-5 minutes of injection) and intermediate duration of efficacy and thus is often favored in the outpatient setting for pre-incisional injections. Of note, however, its effects general only last up to 2 hours. Epinephrine (adrenaline) vasoconstricts arteries, delaying the resorption of lidocaine, and thus almost doubles the duration of anesthesia.</description>
    <arm_group_label>0.5% lidocaine with epinephrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline with epinephrine</intervention_name>
    <description>Several mechanisms could explain the inability to void postoperatively, including nerve conduction impairment from anesthesia. Multiple studies have investigated the use of various types of anesthesia and downstream effects on postoperative urinary retention. It is postulated that denervating the regional pelvic nerves for pain control may lead to denervation of the bladder for a transient period of time, block both the afferent and efferent pathways of the voiding mechanism, affect the urethral retro-resistance pressure and impact urethral length thereby contributing to voiding dysfunction postoperatively. The use of normal saline in this setting may have a reduction in rates and duration of postoperative urinary retention following retropubic midurethral sling placement.</description>
    <arm_group_label>Normal saline with epinephrine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  English speaking

          -  Competent to give consent

        Exclusion Criteria:

          -  A known intolerance or allergic reaction to local anesthetics

          -  Planned spinal anesthesia for the procedure

          -  Planned concomitant prolapse repair other than anterior repair

          -  Preoperative voiding dysfunction as evidenced by a postvoid residual (PVR) of 150 mL
             or greater.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lindsay Turner, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Obstetrics and Gynecology, Allegheny Health Network</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Parda</last_name>
    <phone>412-359-8084</phone>
    <email>David.Parda@ahn.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>West Penn Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsay Turner, MD</last_name>
      <email>Lindsay.TURNER@ahn.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>ICOPE guidelines - World Health Organization. https://www.who.int/ageing/publications/guidelines-icope/en/</citation>
  </reference>
  <reference>
    <citation>Due√±as-Garcia OF, Patterson D, De la Luz Nieto M, Leung K, Flynn MK. Voiding Function After Midurethral Slings With and Without Local Anesthetic: Randomized Controlled Trial. Female Pelvic Med Reconstr Surg. 2017 Jan/Feb;23(1):56-60.</citation>
    <PMID>27682748</PMID>
  </reference>
  <reference>
    <citation>Bracken JN, Huffaker RK, Yandell PM, Handcock T, Higgins EW, Kuehl TJ, Shull BL. A randomized comparison of bupivacaine versus saline during placement of tension-free vaginal tape. Female Pelvic Med Reconstr Surg. 2012 Mar-Apr;18(2):93-6. doi: 10.1097/SPV.0b013e3182436655.</citation>
    <PMID>22453319</PMID>
  </reference>
  <reference>
    <citation>Nilsson CG, Kuuva N, Falconer C, Rezapour M, Ulmsten U. Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12 Suppl 2:S5-8.</citation>
    <PMID>11450979</PMID>
  </reference>
  <reference>
    <citation>Nilsson CG, Falconer C, Rezapour M. Seven-year follow-up of the tension-free vaginal tape procedure for treatment of urinary incontinence. Obstet Gynecol. 2004 Dec;104(6):1259-62.</citation>
    <PMID>15572486</PMID>
  </reference>
  <reference>
    <citation>Mazloomdoost D, Pauls RN, Hennen EN, Yeung JY, Smith BC, Kleeman SD, Crisp CC. Liposomal bupivacaine decreases pain following retropubic sling placement: a randomized placebo-controlled trial. Am J Obstet Gynecol. 2017 Nov;217(5):598.e1-598.e11. doi: 10.1016/j.ajog.2017.07.001. Epub 2017 Jul 8.</citation>
    <PMID>28694151</PMID>
  </reference>
  <reference>
    <citation>Nicolle LE. Catheter associated urinary tract infections. Antimicrob Resist Infect Control. 2014 Jul 25;3:23. doi: 10.1186/2047-2994-3-23. eCollection 2014. Review.</citation>
    <PMID>25075308</PMID>
  </reference>
  <reference>
    <citation>Balakrishnan K, Ebenezer V, Dakir A, Kumar S, Prakash D. Bupivacaine versus lignocaine as the choice of locall anesthetic agent for impacted third molar surgery a review. J Pharm Bioallied Sci. 2015 Apr;7(Suppl 1):S230-3. doi: 10.4103/0975-7406.155921. Review.</citation>
    <PMID>26015720</PMID>
  </reference>
  <reference>
    <citation>Petros PE, Ulmsten UI. An integral theory of female urinary incontinence. Experimental and clinical considerations. Acta Obstet Gynecol Scand Suppl. 1990;153:7-31. Review.</citation>
    <PMID>2093278</PMID>
  </reference>
  <reference>
    <citation>Duckett JR, Patil A, Papanikolaou NS. Predicting early voiding dysfunction after tension-free vaginal tape. J Obstet Gynaecol. 2008 Jan;28(1):89-92. doi: 10.1080/01443610701811837.</citation>
    <PMID>18259908</PMID>
  </reference>
  <reference>
    <citation>Choi S, Mahon P, Awad IT. Neuraxial anesthesia and bladder dysfunction in the perioperative period: a systematic review. Can J Anaesth. 2012 Jul;59(7):681-703. doi: 10.1007/s12630-012-9717-5. Epub 2012 Apr 26. Review. Erratum in: Can J Anaesth. 2017 Dec 18;:.</citation>
    <PMID>22535232</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 20, 2019</study_first_submitted>
  <study_first_submitted_qc>April 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2019</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West Penn Allegheny Health System</investigator_affiliation>
    <investigator_full_name>Charlie Miller</investigator_full_name>
    <investigator_title>Resident Physician, Department of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
    <mesh_term>Urinary Retention</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

